AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (757.2 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Research | Publishing Language: Chinese

Intervention effects of supplementing a stereospecific structured lipid composition on lipid profile in patients with mild hyperlipidemia: a randomized controlled clinical trival

Xinsheng Zhang1, Yulu Wei2, Chunjian Lyu3, Lu Liu1, Zhimeng Yu1, Jinran Yang1, Liya Li1, Yinghua Liu1( )
Department of Nutrition, First Medical Center, Chinese PLA General Hospital, Beijing 100853, China
Department of Clinical Nutrition, Affiliated Hospital of Yangzhou University, Yangzhou Maternal and Child Health Hospital, Yangzhou 225000, Jiangsu Province, China
Department of Nutrition, Fourth Medical Center, Chinese PLA General Hospital, Beijing 100048, China
Show Author Information

Abstract

Objective

To observe the lipid-modulating and anti-inflammatory effects of supplementing a stereospecific structured lipid composition in patients with mild hyperlipidemia.

Methods

This prospective randomized controlled trial enrolled 100 patients with mild hyperlipidemia from the First Medical Center of Chinese PLA General Hospital from March to June 2024. They were randomly divided into a stereospecific structured lipid composition group (intervention group) and a control group, with 50 patients in each group. The intervention group received stereospecific structured lipid capsules (3 capsules tid) alongside standardized lifestyle modifications (low-salt, low-fat diet and exercise guidance), and the control group received only lifestyle modifications. The intervention lasted for three months in both groups. After the intervention, the intake of the three major nutrients, body composition, blood biochemistry, and high-sensitivity C-reactive protein (hs-CRP) were compared between the two groups. SPSS 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test, χ2 test or Fisher′s exact probability method depending on data type.

Results

A total of 95 patients completed the study, 47 in the intervention group and 48 in the control group. Baseline characteristics showed no statistically significant differences between the two groups (P>0.05). Post-intervention analysis revealed no statistically significant differences between the two groups in nutrient intake, body composition, and safety parameters (P>0.05), and in blood biochemical parameters including liver function, kidney function, blood glucose, and protein indicators (P>0.05). After the intervention, the levels of total cholesterol (TC) [(4.26±1.08) vs (5.79±1.12) mmol/L], low-density lipoprotein cholesterol (LDL-C) [(3.16±0.72) vs (4.45±0.62) mmol/L], non-high-density lipoprotein cholesterol (non-HDL-C) [(3.05±0.82) vs (3.70±0.96) mmol/L], hs-CRP [(0.57±0.23) vs (0.87±0.31) mg/dl], and hs-CRP/HDL-C [(0.47±0.22) vs (0.67±0.25)] in the intervention group were significantly lower than those before the intervention (P<0.05). In the control group, LDL-C was significantly lower after the intervention than before the intervention [(3.52±0.95) vs (4.60±0.58) mmol/L; P<0.05], while non-HDL-C was significantly higher [(4.78±0.63) vs (3.68±1.02) mmol/L; P<0.05]. The intervention group demonstrated significantly lower TG [(1.62±1.11) vs (2.21±1.32) mmol/L], LDL-C [(3.16±0.72) vs (3.52±0.95) mmol/L], non-HDL-C [(3.05±0.82) vs (4.78±0.63) mmol/L], hs-CRP [(0.57±0.23) vs (0.73±0.35) mg/dl], and hs-CRP/HDL-C [(0.47±0.22) vs (0.64±0.36)] than those in the control group (P<0.05).

Conclusion

Supplementing a stereospecific structured lipid composition improves blood lipid profiles and inflammation in patients with mild hyperlipidemia without adverse effects on hepatorenal function, playing a role in reducing the risk of atherosclerotic cardiovascular diseases.

CLC number: R692.5; R459.5; R592 Document code: A

References

【1】
【1】
 
 
Chinese Journal of Multiple Organ Diseases in the Elderly
Pages 81-86

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang X, Wei Y, Lyu C, et al. Intervention effects of supplementing a stereospecific structured lipid composition on lipid profile in patients with mild hyperlipidemia: a randomized controlled clinical trival. Chinese Journal of Multiple Organ Diseases in the Elderly, 2026, 25(2): 81-86. https://doi.org/10.11915/j.issn.1671-5403.2026.02.019

7

Views

0

Downloads

0

Crossref

Received: 11 March 2025
Accepted: 16 June 2025
Published: 28 February 2026
© 2026 Chinese Journal of Multiple Organ Diseases in the Elderly